Sagimet Biosciences INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Sagimet Biosciences Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 12, 2026, to be held virtually.
NASDAQ
Sagimet Biosciences prepares for its 2025 Annual Meeting with director elections and ratification of its accounting firm, while also navigating board restructuring.
NASDAQ
DEFA14A: Sagimet Biosciences Inc. to Hold Annual Stockholder Meeting, Elect Directors, and Ratify Auditor
Sagimet Biosciences Inc. will hold its annual stockholder meeting on June 5, 2024, to elect Class I directors and ratify the appointment of Deloitte & Touche LLP as its independent auditor.
NASDAQ
Sagimet Biosciences announces its 2024 Annual Meeting of Stockholders to be held virtually on June 5, 2024, featuring proposals for director elections and ratification of the company's independent accounting firm.